Cargando…
Increased platelet reactivity in patients with late-stage metastatic cancer
Platelet hyperreactivity is associated with an increased risk of thrombosis. Cancer patients are at an increased risk of thrombosis, a risk that increases with disease progression. While cancer patients show evidence of platelet activation in vivo, few studies have extensively assessed whether these...
Autores principales: | Cooke, Niamh M, Egan, Karl, McFadden, Siobhan, Grogan, Liam, Breathnach, Oscar S, O'Leary, John, Hennessy, Bryan T, Kenny, Dermot |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Science Inc
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3799291/ https://www.ncbi.nlm.nih.gov/pubmed/24156029 http://dx.doi.org/10.1002/cam4.86 |
Ejemplares similares
-
Aspirin and P2Y(12) inhibition attenuate platelet-induced ovarian cancer cell invasion
por: Cooke, Niamh M., et al.
Publicado: (2015) -
Similar overall survival with reduced vs. standard dose bevacizumab monotherapy in progressive glioblastoma
por: Gleeson, Jack Patrick, et al.
Publicado: (2019) -
The cost of cancer care: how far would you go for a trial?
por: Fitzpatrick, Orla M., et al.
Publicado: (2022) -
One year of procarbazine lomustine and vincristine is poorly tolerated in low grade glioma: a real world experience in a national neuro-oncology centre
por: Keogh, Rachel J., et al.
Publicado: (2021) -
An observational study of dose dense chemotherapy with lipegfilgrastim support in early breast cancer
por: Rashed, Ahmed, et al.
Publicado: (2023)